gdc

Lung Cancer

How My Metastatic Lung Cancer Diagnosis Struck a New Chord in Me
Patient StoriesLung CancerMen's Health
When singer-songwriter Josh Colow started losing weight, feeling nauseous, and had a fever that wouldn’t go away, the last thing on his mind was lung cancer. Find out how his devastating diagnosis changed his attitude and perspective.
Drugs for Lung Cancer
Lung Cancer
Find financial assistance programs available for lung cancer drugs.
Looking at Lung Cancer without Stigma
Lung CancerIssue Introductions
In her introduction to this special issue on Lung Cancer, Lillie emphasizes that we need to inspire and help people to stop smoking, and get rid of the overall stigma surrounding this disease.
Becoming a Patient Advocate After a Small-Cell Lung Cancer Diagnosis at Age 28
Patient StoriesLung CancerPatient Advocacy
Montessa Lee’s pain persisted after an initial visit to the doctor and a misdiagnosis. Finally, an x-ray in the emergency room revealed a 15-cm mass on her left lung. Read how she turned anger into action.
Immunotherapy Beneficial in Patients with Early-Stage Non–Small-Cell Lung Cancer and PD-L1 Expression
Lung CancerImmunotherapyBiomarkers
For the first time, the use of immunotherapy after surgical removal of the tumor and chemotherapy has shown benefits in patients with early-stage non–small-cell lung cancer (NSCLC) and PD-L1 expression, a biomarker found in some patients with NSCLC.
Tecentriq First Immunotherapy Approved for Adjuvant Treatment of Patients with Early-Stage NSCLC and PD-L1 Expression
FDA Approvals, News & UpdatesLung Cancer
On October 15, 2021, the FDA approved a new indication for Tecentriq (atezolizumab) for adjuvant (additional) treatment of patients with stage II-IIIA non–small-cell lung cancer and PD-L1 expression, after surgical removal of the tumor and chemotherapy. This is the first immunotherapy approved for patients with early-stage lung cancer.
The Pandemic Is Not Over: Staying Connected and Receiving Encouragement While Living with Lung Cancer
Patient StoriesLung Cancer
On his lonely journey dealing with lung cancer, Ron Simmons found that connecting with others who had lung cancer helped him create a sense of purpose and gave him a mission moving forward.
Exkivity Second FDA-Approved Oral Targeted Therapy for Patients with Metastatic NSCLC and EGFR Exon 20 Insertion Mutations
FDA Approvals, News & UpdatesLung Cancer
On September 15, 2021, the FDA approved Exkivity (mobocertinib) capsules, an oral kinase inhibitor, for the treatment of adults with locally advanced or metastatic non–small-cell lung cancer (NSCLC) and EGFR exon 20 insertion mutations whose disease progressed during or after platinum-based chemotherapy, a cancer with few treatment options.
Clinical Trial Aims to Reduce Malnutrition in Patients with Lung Cancer
Nutrition & CancerLung CancerClinical Trials
Combating malnutrition should be at the forefront of cancer care, as studies have shown that up to 80% of patients with cancer are malnourished at some point during their treatment. Dr. Spees describes a new clinical trial focused on improving the nutrition of patients with lung cancer.
Page 1 of 12
Results 1 - 10 of 115

Subscribe to CONQUER: the patient voice

Receive timely cancer news & updates, patient stories, and more.


Country
Race or Ethnicity
Gender
Profession or Role
Primary Interest